Literature DB >> 11433616

[Combined neoplasia of the lung: description of a case of adenocarcinoma mixed with typical carcinoid].

A Cavazza1, R Toffanetti, G Ferrari, S Piana, I Putrino, G Gardini.   

Abstract

OBJECTIVE: To report about a lung tumor that was a combination of typical carcinoid and adenocarcinoma. RESULTS AND
CONCLUSIONS: The patient, a 71-year-old male, presented with a 2.5-cm pulmonary nodule that, microscopically, was a combination of an adenocarcinoma (tubular with clear cell features and bronchioloalveolar) and a typical carcinoid. Immunohistochemically, both components were positive for cytokeratin, but only the carcinoid component was positive for chromogranin and synaptophysin. In the range of neuroendocrine tumors of the lung, a combination with other histological types of carcinoma (squamous, adeno, large cell and pleomorphic) can be found with both small cell carcinoma and large cell neuroendocrine carcinoma, but is very rare with typical and atypical carcinoids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433616

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  3 in total

1.  Pulmonary hamartoma associated with typical carcinoid/tumorlet.

Authors:  Alberto Cavazza; Massimiliano Paci; Giulio Rossi
Journal:  Virchows Arch       Date:  2006-08-16       Impact factor: 4.064

2.  Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Domenico Galetta; Federica Perrone; Paola Braidotti; Michela Manzotti; Alessandra Fabbri; Lorenzo Spaggiari; Giulia Veronesi; Giuseppe Viale
Journal:  Virchows Arch       Date:  2011-01-06       Impact factor: 4.064

3.  Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma.

Authors:  Giovanni Fellegara; Tiziana D'Adda; Francesco P Pilato; Elisabetta Froio; Luca Ampollini; Michele Rusca; Guido Rindi
Journal:  Virchows Arch       Date:  2008-06-13       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.